Overview
The SICCA International Registry was developed to track and gain a broader knowledge of the disease. It involved a global group of clinical and laboratory investigators from in Argentina, China, Denmark, Japan, United Kingdom (UK), India, and the United States. These sites worked together to study individuals diagnosed or suspected of having Sjögren’s disease (SjD). This collaborative group of scientists was known as the Sjögren’s International Collaborative Clinical Alliance (SICCA). Our branch of the study was conducted at Johns Hopkins for a number of years and was directed by Dr. Alan Baer.
The SICCA International Registry had three objectives. The first objective, which was met, was to develop standardized diagnostic criteria for Sjögren’s disease. The second objective was to concurrently oversee the collection, processing and storage of clinical data and biospecimens (tears, saliva, and blood) from patients, their family members and controls. The third objective was to develop a data and biospecimen bank from which these resources could be provided to qualified investigators with projects focused on SjD.
Key Facts
- Status: Completed
- Principal Investigator: Alan N. Baer, MD
- Dates: 2009 – 2014
- Location: Johns Hopkins University
Study Design
The study used clinical findings and evaluation of patients and their clinical status, as well as collected biospecimens such as tears, saliva and blood.
Impact
This research has provided valuable knowledge about Sjögren’s disease and how to properly assess and diagnose the disease.
